Physician profile
Richard Ursone
NPI 1528059722
$1,550.72
in general payments reported to CMS, 2019-2025
9 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2020: $335 · 2021: $265 · 2022: $12.88 · 2023: $335 · 2024: $96.45 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $908.73 | 2019-2024 | Mako, Accolade |
| Pacira Therapeutics, INC. | $280.01 | 2019-2020 | |
| Think Surgical, INC. | $131.25 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $111.90 | 2019-2022 | |
| Heron Therapeutics, INC. | $33.62 | 2024 | Zynrelef |
| Biocomposites INC | $31.43 | 2024 | |
| Orthofix Medical, INC. | $28.35 | 2023-2024 | Physio-Stim, Spinal-Stim |
| Depuy Synthes Sales INC. | $16.17 | 2019 | |
| Heraeus Medical, LLC. | $9.26 | 2023 | Palacos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Ursone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.